Cargando…
Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
BACKGROUND: Clopidogrel has been widely used to prevent recurrent ischemia in patients with acute coronary syndrome (ACS). However, inter-individual variability in response to clopidogrel has been a problem in the clinical setting. The aim of the present study was to investigate the frequency of clo...
Autores principales: | Park, Kyoung-Jin, Chung, Hae-Sun, Kim, Suk-Ran, Kim, Hee-Jin, Han, Ju-Yong, Lee, Soo-Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116006/ https://www.ncbi.nlm.nih.gov/pubmed/21474982 http://dx.doi.org/10.3343/kjlm.2011.31.2.91 |
Ejemplares similares
-
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
por: Alvitigala, Bhawani Yasassri, et al.
Publicado: (2020) -
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
por: Rouits, E, et al.
Publicado: (2008) -
Effect of Atorvastatin and Clopidogrel Co-Administration After Coronary Stenting in Korean Patients With Stable Angina
por: Kim, Goeng Bae, et al.
Publicado: (2011) -
2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018) -
Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)